Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 149,287 | N/A | N/A |
| Receivables | 18,671 | N/A | N/A |
| Inventories | 179 | N/A | N/A |
| Other current assets | 7,266 | 0 | 0 |
| TOTAL | $175,403 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 3,468 | N/A | N/A |
| Intangibles | 1,363 | 0 | 0 |
| Other Non-Current Assets | 2,627 | 0 | 0 |
| TOTAL | $7,459 | $N/A | $N/A |
| Total Assets | $182,862 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 1,145 | N/A | N/A |
| Accounts payable and accrued liabilities | 13,025 | 0 | 0 |
| Other current liabilities | 6,257 | N/A | N/A |
| TOTAL | $99,481 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 3,753 | N/A | N/A |
| Deferred Revenues | 79,053 | N/A | N/A |
| Other Non-Current Liabilities | 1,847 | 0 | 0 |
| TOTAL | $4,281 | $N/A | $N/A |
| Total Liabilities | $103,762 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1,956 | N/A | N/A |
| Retained earnings | -176,087 | N/A | N/A |
| Other shareholders' equity | -3,018 | 0 | 0 |
| TOTAL | $79,100 | $N/A | $N/A |
| Total Liabilities And Equity | $182,862 | $0 | $0 |